| Size & multiples | |||
| Market Cap | $2.00B | Enterprise Value | $2.11B |
| P/E (TTM) | 29.29× | PEG (trailing) | 1.71× |
| P/S | 3.28× | P/FCF | 28.33× |
| EV/EBITDA | 18.92× | EV/EBIT | 22.84× |
| EV/Sales | 3.47× | EV/FCF | 30.00× |
| FCF Yield | 3.53% | Buyback Yield | — |
| Owner Earnings (TTM) | $76.9M | Owner Earnings Yield | 3.85% |
| Shareholder Yield | — | ||
| Cost of capital & EVAmethodology → | |||
| Beta (5y monthly) | 1.07 | Risk-free (assumed) | 4.00% |
| Equity risk premium (assumed) | 5.00% | Cost of Equity | 9.36% |
| After-tax Cost of Debt | 5.90% | Synthetic credit rating | A+ |
| Cost of Debt · embedded (pre-tax) | 7.12% | Cost of Debt · marginal (synthetic) | 4.70% |
| WACC | 9.13% | ROIC | 14.46% |
| EVA Spread (ROIC−WACC) | 5.32% | EVA | $28.7M |
Synthetic rating = ICR-based credit-quality read (Damodaran), not an agency rating.
Flows TTM (last 4 quarters); latest annual for: Interest Expense · EPS TTM $8.81 · revenue TTM $608.9M · FCF TTM $70.5M
Output of a disclosed model whose assumptions may be wrong — research information, not investment advice. See the Disclaimer.
Rich vs Health Care on P/E, EV/EBITDA
P/E 61st · EV/EBITDA 64th percentile in the Health Care pool — placement read per multiple; the API emits no single blended figure, so none is shown.
Compared against all 1054 Health Care names we cover — one sector-wide pool, so the median skews toward smaller (often unprofitable) companies. Try the Size band for a cap-matched read.
| Metric | This (FY) | Peer median | IQR (25–75) | %ile |
|---|---|---|---|---|
| P/E | 29.5x | 24.4x | 13.0x–39.3x | 61 ↑rich |
| EV/EBITDA | 18.9x | 15.1x | 9.8x–24.4x | 64 ↑rich |
| FCF Yield | 4.1% | -7.8% | -34.7%–1.4% | 84 ↑strong |
| Net Margin | 11.3% | -21.2% | -325.3%–7.2% | 81 ↑strong |
| Operating Margin | 15.3% | -34.5% | -552.0%–8.0% | 86 ↑strong |
| ROE | 17.8% | -36.8% | -92.5%–4.5% | 88 ↑strong |
